619 related articles for article (PubMed ID: 12481824)
1. Exploiting current understanding of antibiotic action for discovery of new drugs.
Chopra I; Hesse L; O'Neill AJ
Symp Ser Soc Appl Microbiol; 2002; (31):4S-15S. PubMed ID: 12481824
[TBL] [Abstract][Full Text] [Related]
2. Exploiting current understanding of antibiotic action for discovery of new drugs.
Chopra I; Hesse L; O'Neill AJ
J Appl Microbiol; 2002; 92 Suppl():4S-15S. PubMed ID: 12000608
[TBL] [Abstract][Full Text] [Related]
3. [Development of antituberculous drugs: current status and future prospects].
Tomioka H; Namba K
Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
[TBL] [Abstract][Full Text] [Related]
4. Combating bacteria and drug resistance by inhibiting mechanisms of persistence and adaptation.
Smith PA; Romesberg FE
Nat Chem Biol; 2007 Sep; 3(9):549-56. PubMed ID: 17710101
[TBL] [Abstract][Full Text] [Related]
5. Genomic approaches to antibacterial discovery.
Payne DJ; Gwynn MN; Holmes DJ; Rosenberg M
Methods Mol Biol; 2004; 266():231-59. PubMed ID: 15148422
[TBL] [Abstract][Full Text] [Related]
6. Bacterial targets to antimicrobial leads and development candidates.
Rogers BL
Curr Opin Drug Discov Devel; 2004 Mar; 7(2):211-22. PubMed ID: 15603255
[TBL] [Abstract][Full Text] [Related]
7. Use of genomics to select antibacterial targets.
Pucci MJ
Biochem Pharmacol; 2006 Mar; 71(7):1066-72. PubMed ID: 16412986
[TBL] [Abstract][Full Text] [Related]
8. New screens and targets in antibacterial drug discovery.
Falconer SB; Brown ED
Curr Opin Microbiol; 2009 Oct; 12(5):497-504. PubMed ID: 19651534
[TBL] [Abstract][Full Text] [Related]
9. Old and new targets of antibacterial therapy.
Dbaibo GS
J Med Liban; 2000; 48(4):177-81. PubMed ID: 11214186
[TBL] [Abstract][Full Text] [Related]
10. [Bacterial type II topoisomerases as targets for antibacterial drugs].
Pietrusiński M; Staczek P
Postepy Biochem; 2006; 52(3):271-82. PubMed ID: 17201062
[TBL] [Abstract][Full Text] [Related]
11. Postgenomic strategies in antibacterial drug discovery.
Brötz-Oesterhelt H; Sass P
Future Microbiol; 2010 Oct; 5(10):1553-79. PubMed ID: 21073314
[TBL] [Abstract][Full Text] [Related]
12. Highly sensitive target-based whole-cell antibacterial discovery strategy by antisense RNA silencing.
Singh SB; Phillips JW; Wang J
Curr Opin Drug Discov Devel; 2007 Mar; 10(2):160-6. PubMed ID: 17436551
[TBL] [Abstract][Full Text] [Related]
13. Efflux systems in bacterial pathogens: an opportunity for therapeutic intervention? An industry view.
Lynch AS
Biochem Pharmacol; 2006 Mar; 71(7):949-56. PubMed ID: 16290174
[TBL] [Abstract][Full Text] [Related]
14. [Means of bacterial resistance].
Moreillon P
Rev Med Suisse Romande; 2000 Aug; 120(8):641-50. PubMed ID: 11028184
[TBL] [Abstract][Full Text] [Related]
15. β-Lactam and glycopeptide antibiotics: first and last line of defense?
Jovetic S; Zhu Y; Marcone GL; Marinelli F; Tramper J
Trends Biotechnol; 2010 Dec; 28(12):596-604. PubMed ID: 20970210
[TBL] [Abstract][Full Text] [Related]
16. A multivalent approach to drug discovery for novel antibiotics.
Long DD; Aggen JB; Christensen BG; Judice JK; Hegde SS; Kaniga K; Krause KM; Linsell MS; Moran EJ; Pace JL
J Antibiot (Tokyo); 2008 Oct; 61(10):595-602. PubMed ID: 19168973
[TBL] [Abstract][Full Text] [Related]
17. Does the cell wall of bacteria remain a viable source of targets for novel antibiotics?
Silver LL
Biochem Pharmacol; 2006 Mar; 71(7):996-1005. PubMed ID: 16290173
[TBL] [Abstract][Full Text] [Related]
18. Application of SBDD to the discovery of new antibacterial drugs.
Finn J
Methods Mol Biol; 2012; 841():291-319. PubMed ID: 22222458
[TBL] [Abstract][Full Text] [Related]
19. Antibacterial drug discovery and structure-based design.
Barker JJ
Drug Discov Today; 2006 May; 11(9-10):391-404. PubMed ID: 16635801
[TBL] [Abstract][Full Text] [Related]
20. Novel target sites in bacteria for overcoming antibiotic resistance.
Black MT; Hodgson J
Adv Drug Deliv Rev; 2005 Jul; 57(10):1528-38. PubMed ID: 15949866
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
